Why some cancers may respond poorly to key drugs discovered
(University of Texas at Austin) Scientists have identified a driver of drug resistance in breast, ovarian and prostate cancers that may help doctors predict which patients will become resistant to a class of drugs frequently used to treat BRCA 1/2-deficient tumors.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Prostate Cancer | Texas University